Substance Use and Utilization of Prenatal and Postpartum Care
- PMID: 33758116
- PMCID: PMC8449796
- DOI: 10.1097/ADM.0000000000000843
Substance Use and Utilization of Prenatal and Postpartum Care
Abstract
Objectives: Prenatal and postpartum care for women with substance use is important due to increased risk of poor health outcomes. The influence of substance use on perinatal care utilization is not well characterized, especially postpartum care. The objective of this study was to examine the effect of substance use during pregnancy on prenatal and postpartum care utilization in a nationally representative sample and to identify maternal characteristics associated with inadequate prenatal and postpartum care among women with substance use.
Methods: Pregnancy Risk Assessment Monitoring System data (2016-2018) from 8 states were used for this study. Logistic regression models adjusted for complex survey weights and confounder variables were used to estimate the odds of not receiving adequate prenatal care and postpartum care. Weighted Rao-Scott chi-square tests were used to examine maternal characteristics associated with care utilization among women who reported substance use during pregnancy.
Results: The study included 15,131 women, with 5.3% who reported illicit substance use during pregnancy. In multivariable models, substance use was associated with an increase in the odds of not receiving adequate prenatal care (OR 1.69, CI 1.32, 2.17) and not receiving postpartum care (OR: 1.47, CI 1.10, 1.95). Among women who reported substance use, depression and smoking status were associated with not receiving adequate prenatal or postpartum care.
Conclusions: Substance use during pregnancy is independently associated with disparities in prenatal and postpartum care access. Future studies are needed to identify how barriers lead to care inequalities and importantly, to identify strategies to improve care utilization.
Copyright © 2021 American Society of Addiction Medicine.
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566–576. - PubMed
-
- Hwang SS, Diop H, Liu CL, et al. Maternal Substance Use Disorders and Infant Outcomes in the First Year of Life among Massachusetts Singletons, 2003–2010. J Pediatr. 2017;191:69–75. - PubMed
-
- Edelson PK, Bernstein SN. Management of the Cardiovascular Complications of Substance Use Disorders During Pregnancy. Curr Treat Options Cardiovasc Med. 2019;21(11):73. - PubMed
-
- Cook JL, Green CR, de la Ronde S, et al. Epidemiology and Effects of Substance Use in Pregnancy. J Obstet Gynaecol Can. 2017;39(10):906–915. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
